| Date Filed | Type | Description |
| 10/04/2023 |
4
| BIOTECH TARGET N V (10% Owner) has filed a Form 4 on MACROGENICS INC|
Txns:
| Bought 150,000 shares
@ $4.4639, valued at
$669.6k
|
|
| 08/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| BIOTECH GROWTH N V (10% Owner) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Bought 1,000,000 shares
@ $5, valued at
$5M
|
|
| 06/29/2023 |
4
| BIOTECH GROWTH N V (10% Owner) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Bought 1,740,000 shares
@ $5.4914, valued at
$9.6M
|
|
| 05/15/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/14/2023 |
SC 13G/A
| BB BIOTECH AG reports a 14.5% stake in MACROGENICS, INC. |
| 02/14/2023 |
SC 13G/A
| BB BIOTECH AG reports a 5.2% stake in WAVE LIFE SCIENCES LTD. |
| 02/14/2023 |
SC 13G/A
| BB BIOTECH AG reports a 6.8% stake in IONIS PHARMACEUTICALS, INC. |
| 02/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 01/23/2023 |
4
| BIOTECH TARGET N V (10% Owner) has filed a Form 4 on MACROGENICS INC|
Txns:
| Bought 150,000 shares
@ $5.2995, valued at
$794.9k
|
|
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/30/2022 |
SC 13D/A
| BB BIOTECH AG reports a 0% stake in Radius Health, Inc. |
| 08/30/2022 |
4
| BIOTECH TARGET N V (10% Owner) has filed a Form 4 on Radius Health, Inc.|
Txns:
| Unknown transaction of 8,733,538 shares
@ $10, valued at
$87.3M
|
|
| 08/11/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 07/20/2022 |
4
| BIOTECH GROWTH N V (10% Owner) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Bought 300,000 shares
@ $3.1558, valued at
$946.7k
|
|
| 07/18/2022 |
4
| BIOTECH GROWTH N V (10% Owner) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Bought 347,204 shares
@ $2.7921, valued at
$969.4k
Bought 241,665 shares
@ $3.1316, valued at
$756.8k
|
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 04/29/2022 |
4
| BIOTECH GROWTH N V (10% Owner) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Bought 150,000 shares
@ $2.6632, valued at
$399.5k
Bought 255,711 shares
@ $2.5727, valued at
$657.9k
|
|
| 04/28/2022 |
4
| BIOTECH GROWTH N V (10% Owner) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Sold 25,100 shares
@ $5.8536, valued at
$146.9k
|
|
| 04/20/2022 |
4
| BIOTECH GROWTH N V (10% Owner) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Bought 150,000 shares
@ $3.2929, valued at
$493.9k
Bought 150,000 shares
@ $3.2443, valued at
$486.6k
|
|
| 04/14/2022 |
4
| BIOTECH GROWTH N V (10% Owner) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Bought 150,000 shares
@ $3.424, valued at
$513.6k
Bought 102,556 shares
@ $3.5709, valued at
$366.2k
|
|
|